India rejects Gilead’s Hepatitis C drug patent request

(Reuters) - India's patent office has rejected an application from U.S.-based Gilead Sciences Inc for its…

India rejects Gilead’s Hepatitis C drug patent request

As Gilead is the sole producer of sofosbuvir (no generic versions have been launched in any…